In an exclusive reveal to EU-Startups, Paris-based Klaimy, an AI-powered SaaS platform transforming medical data processing for insurers, has raised €1.2 million in pre-Seed funding to scale its engineering and data science teams, expand its product capabilities, and accelerate commercial rollout across Europe.
The funding round was led by Insurtech Gateway, with participation from U-Investors, Tenity, and strategic angel investors with insurance experience.
Amira Nakouri, CEO at Klaimy, commented: “We’re solving a core pain point that every health & life insurer faces: how to make fast, accurate decisions on complex medical files. Our mission is to turn medical data chaos into clarity—with AI that doesn’t just automate, but truly assists. We’re here to empower insurance teams with the right tools to deliver better decisions, faster.”
Klaimy was founded in 2023 by Amira Nakouri (CEO), Former strategy consultant with 7+ years leading digital insurance transformation; Yazid Hadni (CPO), Expert in AI-driven insurance workflows, built underwriting automation at La Mutuelle Générale; and Juan Barragan (CTO), 15 years in machine learning and software engineering, second-time AI startup Founder.
Klaimy helps insurers process complex medical documents in underwriting and claims with accuracy—acting not as a generic automation tool, but as an AI copilot trained in medical knowledge.
Klaimy’s proprietary AI models are specifically trained on medical semantics and the logic of insurance workflows. The platform transforms every incoming document—regardless of format—into structured, digestible insights that:
- Identify medical risk factors in real time.
- Flag inconsistencies and missing elements.
- Summarise medical history with a 360° chronological view.
- Support both underwriting and claims decisions.
- Reportedly improve auditability and compliance.
With Klaimy, insurers are turning “days of manual file review into just seconds” of automated, explainable output—enabling faster, more accurate, and more scalable operations.
According to figures provided by Klaimy, their AI models are trained on 18,000+ medical datapoint, their accuracy rates are above 98% for medical condition extraction, and their platform is designed to tackle fraud, missing data and clinical inconsistencies.
Richard Chattock, CEO of Insurtech Gateway, commented: “Klaimy’s founding team has an exceptional combination of AI expertise and insurance knowledge, which is exactly what’s needed to tackle the inefficiencies in the underwriting and claims processes. We were impressed by their vision and ability to apply cutting-edge technology to real-world insurance challenges. Their platform is not only simplifying workflows but also significantly improving accuracy and decision-making.
“With this talented team at the helm, Klaimy is well-positioned to drive necessary change in the sector, and we’re thrilled to back them as their innovation brings greater efficiency to the market and an improved experience for policyholders.”
Klaimy beleives that in health & life insurance, underwriters and claims handlers are buried in an avalanche of unstructured, messy, and complex medical documents—PDFs, scans, reports, hospital bills, patient histories.
And yet, every day, someone has to make a decision: Should we underwrite this policy? Is this claim eligible? Is this diagnosis declared?
These decisions are often delayed, inconsistent, and expensive—because they rely on human interpretation of non-standard, clinical data. Klaimy argues that traditional tools can’t handle this.
Driss LARAKI, Managing Partner of U-Investors commented: “We are thrilled to support Klaimy in transforming the insurance sector with an innovative platform that streamlines complex processes and sets a new benchmark for accuracy and operational excellence. By leveraging advanced technologies, they are effectively addressing persistent inefficiencies in underwriting and claims management.
“Behind this innovation is a founding team that uniquely combines deep AI expertise with a strong understanding of the insurance industry—an essential alliance to drive meaningful and lasting change.”
Klaimy’s product roadmap is focused on going beyond document extraction, building the next-generation AI copilot that supports expert decision-making:
- Short term: Enhanced medical understanding and diagnostic modeling.
- Mid term: Risk prediction, fraud detection, and prevention analytics.
- Long term: Digital twin modelling and real-time risk scoring integrated into insurer workflows.
Klaimy will use this pre-Seed round to scale its engineering and data science teams, expand its product capabilities, and accelerate commercial rollout across Europe.
Read the orginal article: https://www.eu-startups.com/2025/04/klaimy-bags-e1-2-million-to-support-medical-underwriters-and-claims-handlers-with-ai-copilot/
